Clinical Trials Finder hero image

Clinical Trials Finder

Clinical trials may offer you additional treatment options in addition to standard treatment options already available and approved to treat your cancer.

A common misconception is that clinical trials are only for people who have tried everything else and are out of options. In fact, a clinical trial may be the best option to treat your cancer at any stage of your cancer journey.

Not every clinical trial is available at every cancer center. Finding a clinical trial that may be an option for you can be difficult to navigate on your own. The KCA is proud to offer our new Clinical Trial Finder that may provide options for you close to home or anywhere in the United States. If a clinical trial that fits your cancer isn’t available now, one may be available in the future, so check back often. Talk to your doctor about clinical trials, including any that you find using the tool below.

The Clinical Trial Finder is intended for patients and caregivers for educational purposes only. Only your doctor can best advise if a clinical trial is appropriate for you. This tool uses information from clinicaltrials.gov and is updated monthly. KCA is not responsible for information provided to clinicaltrials.gov; complete trial information can be found on that website.

Find a Clinical Trial

Trials (164 Results)

Featured Trials

Title Lead Sponsor
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma Arcus Biosciences, Inc.
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer Pfizer

Trials

Title Lead Sponsor
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation Guardant Health, Inc.
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) University of Alabama at Birmingham
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer University of Texas Southwestern Medical Center
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors Zumutor Biologics Inc.
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors VM Discovery, Inc.
Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach Urological Research Network, LLC
Integrated Cancer Repository for Cancer Research University of Nebraska
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors Baylor College of Medicine

Last updated: October 6, 2026

Keep Learning:

The Kidney Cancer Association provides educational literature for anyone impacted by kidney cancer.

Request your free copy today